During the past decade, Cardiovascular Imaging Technologies conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cardiovascular Imaging Technologies" #1 collaborator was "GE Healthcare" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Cardiovascular Imaging Technologies" are "Cardiomyopathy" (1 trials), "Coronary Artery Disease (CAD)" (1 trials), "Heart Failure" (1 trials), "Myocardial Ischemia" (1 trials) and "Myocardial Perfusion Imaging" (1 trials). Many other conditions were trialed in "Cardiovascular Imaging Technologies" in a lesser frequency.

Most popular intervention types in "Cardiovascular Imaging Technologies" are "Drug" (3 trials), "Procedure" (2 trials), "Behavioral" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "AdreView" (1 trials), "Exercise" (1 trials), "Placebo to match ranolazine" (1 trials), "Ranolazine" (1 trials) and "Regadenoson" (1 trials). Other intervention names were less common.

The vast majority of trials in "Cardiovascular Imaging Technologies" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Cardiovascular Imaging Technologies". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Cardiovascular Imaging Technologies, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Cardiovascular Imaging Technologies, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".